Preclinical results were presented recently at the EAO meeting for Straumann`s innovative hydrogel-based membrane, which confirmed the product`s efficacy and ease of handling. The first clinical trial was successfully completed in the third quarter, with each of the endpoints being met. On this basis, applications for regulatory clearance should be submitted in the current quarter. Straumann and Kuros Biosurgery, a spin-off from the Swiss Federal Institute, ETHZ and the University of Zurich, applied for a patent on this technology in 2003.
Welcome to OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.